Mustafa Akça1, Alper Ata2, Erdinç Nayır3, Süleyman Erdoğdu3, Ali Arıcan3. 1. Department of Internal Medicine, Mersin University, Faculty of Medicine, Mersin, Turkey. 2. Clinic of Medical Oncology, Mersin State Hospital, Mersin, Turkey. 3. Department of Medical Oncology, Mersin University, Faculty of Medicine, Mersin, Turkey.
Abstract
OBJECTIVE: Breast cancer can lead to alterations in quality of life of the patients. The aim of this study is to evaluate the changes in quality of life of the female patients who had undergone surgical treatment for breast cancer. MATERIALS AND METHODS: A total of 250 female patients (breast-preserving surgery (BPS), n=27, 11%; modified radical mastectomy (MRM), n=194, 77%, and simple mastectomy (SM), n=29; 11%) aged between 28-55 years (47.4±6.4 yrs) were included in the study. Patient information, demographic characteristics, income, and treatment modalities applied were recorded. Validated Turkish versions of EORTC QLQ-C30, and EORTC-BR23 questionnaires were used for all patients. RESULTS: Breast-preserving surgery has a more favorable impact on general well-being, physical role, cognitive, psychological, and social functions, and symptom scale scores. When the identical parameters were taken into consideration, relatively favorable outcomes of BPS on the patients were observed relative to mastectomized patients. Besides, though not statistically significant, BPS has more patient-friendly effects on sexual function and sexual satisfaction in comparison with mastectomy. Patients with advanced stage disease and elder patients had more unfavorable health related quality of life (HRQoL) scores than younger patients, and those in their early stages of breast cancer. CONCLUSION: Quality of life of BPS patients is less adversely affected relative to mastectomized patients. In the decision-making process, quality of life should be taken into consideration.
OBJECTIVE:Breast cancer can lead to alterations in quality of life of the patients. The aim of this study is to evaluate the changes in quality of life of the female patients who had undergone surgical treatment for breast cancer. MATERIALS AND METHODS: A total of 250 female patients (breast-preserving surgery (BPS), n=27, 11%; modified radical mastectomy (MRM), n=194, 77%, and simple mastectomy (SM), n=29; 11%) aged between 28-55 years (47.4±6.4 yrs) were included in the study. Patient information, demographic characteristics, income, and treatment modalities applied were recorded. Validated Turkish versions of EORTC QLQ-C30, and EORTC-BR23 questionnaires were used for all patients. RESULTS: Breast-preserving surgery has a more favorable impact on general well-being, physical role, cognitive, psychological, and social functions, and symptom scale scores. When the identical parameters were taken into consideration, relatively favorable outcomes of BPS on the patients were observed relative to mastectomized patients. Besides, though not statistically significant, BPS has more patient-friendly effects on sexual function and sexual satisfaction in comparison with mastectomy. Patients with advanced stage disease and elder patients had more unfavorable health related quality of life (HRQoL) scores than younger patients, and those in their early stages of breast cancer. CONCLUSION: Quality of life of BPSpatients is less adversely affected relative to mastectomized patients. In the decision-making process, quality of life should be taken into consideration.
Entities:
Keywords:
Breast cancer; mastectomy; psychosocial factors; quality of life; sexual activity
Authors: Senem Demirci; Erhan Eser; Zeynep Ozsaran; Deniz Tankisi; Arif B Aras; Gul Ozaydemir; Yavuz Anacak Journal: Asian Pac J Cancer Prev Date: 2011
Authors: Neil W Scott; Peter M Fayers; Neil K Aaronson; Andrew Bottomley; Alexander de Graeff; Mogens Groenvold; Chad Gundy; Michael Koller; Morten A Petersen; Mirjam A G Sprangers Journal: Qual Life Res Date: 2009-02-27 Impact factor: 4.147
Authors: J Kalter; I M Verdonck-de Leeuw; M G Sweegers; N K Aaronson; P B Jacobsen; R U Newton; K S Courneya; J F Aitken; J Armes; C Arving; L J Boersma; A M J Braamse; Y Brandberg; S K Chambers; J Dekker; K Ell; R J Ferguson; M F M Gielissen; B Glimelius; M M Goedendorp; K D Graves; S P Heiney; R Horne; M S Hunter; B Johansson; M L Kimman; H Knoop; K Meneses; L L Northouse; H S Oldenburg; J B Prins; J Savard; M van Beurden; S W van den Berg; J Brug; L M Buffart Journal: Psychooncology Date: 2018-03-15 Impact factor: 3.894